Apitope
develops antigen-specific immunotherapies for the treatment of autoimmune diseases... Read moreApitope
develops antigen-specific immunotherapies for the treatment of autoimmune diseases... Read more
News
Sep 29, 2021
ChinaBio Today
Apitope: Worg Pharma Acquires Apitope's Autoimmune Platform and Pipeline
Jun 12, 2020
European Biotechnology
Apitope: Merck drops MS collaboration with Apitope
Oct 24, 2018
prnewswire
Apitope: Apitope Announces Management Changes
Apr 16, 2018
FierceBiotech
Apitope: Apitope preps Graves' disease drug for phase 2 after positive trial
Apr 03, 2018
Apitope Youtube Channel
Apitope posted a video "Project "DAVIAD": What is Graves' disease?" on YOUTUBE
Mar 22, 2018
PMLiVE
Apitope: Apitope strengthens its board with new director
Feb 27, 2017
BioPortfolio
Apitope: Apitope Announces Positive Phase 2a Data for Relapsing MS Drug
Feb 21, 2017
FinanzNachrichten
Apitope: Apitope Announces Positive ATX-MS-1467 Phase IIa Data in Relapsing Multiple Sclerosis
Feb 07, 2017
Business Wire
Press Release: Apitope : Graves Diseases - Pipeline Review, H2 2016 - Key Companies are Apitope International NV, Nova Therapeutics LLC, Novartis AG, Omeros Corp & Rodos BioTarget GmbH - Research and Markets
Nov 03, 2016
PressReleasePoint
Press Release: Apitope : Apitope Announces Enrolment of First Patient in Phase I Trial of ATX-GD-59 for the Treatment of Graves Disease
Apitope Competitors
1
2
3
4
5
6
7
8
9
10